Sims Trent, Tumin Dmitry, Hayes Don, Tobias Joseph D
Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Department of Pediatric Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
Cardiol Res. 2019 Jun;10(3):157-164. doi: 10.14740/cr870. Epub 2019 Jun 7.
Heart transplantation (HTx) is a treatment option for refractory end-stage heart failure. Severe illness requiring pre-transplant intensive care unit (ICU) stay may be a risk factor for diminished post-transplant survival, but this association is surprisingly inconsistent in recent studies. To clarify the significance of ICU stay as a risk factor for heart transplant outcomes, we aimed to define if patient age was a factor in which ICU stay was predictive of survival after HTx.
De-identified data were obtained on isolated first-time HTx performed during the years 2006 - 2015 from the UNOS Registry. Nine age groups were defined. The primary outcome was 1-year post-transplant mortality. Cox proportional hazard regression estimated unadjusted and adjusted hazard ratio (HR) associated with pre-transplant ICU stay in each age group.
The analysis included 19,508 patients (9% deceased within 1 year). In the overall cohort, pre-transplant ICU stay was associated with increased hazard of 1-year mortality (HR = 1.3; 95% confidence interval (CI): 1.2 - 1.4; P < 0.001); but further univariate analysis showed a greater hazard of 1-year mortality associated with ICU stay in infants (HR = 2.2; 95% CI: 1.5 - 3.2; P < 0.001). However, the adjusted analysis found that adults ages 40 - 49 had the highest statistically significant hazard of 1-year mortality (HR = 1.5; 95% CI: 1.1 - 2.1; P = 0.011).
Our study established age variation in the association between ICU stay and survival after HTx, with this association being strongest among adults, 40 to 49 years of age, undergoing HTx. Previous data suggesting decreased survival in infants may be related to the increased use of extracorporeal membrane oxygenation as a mechanical cardiac assist rather than ventricular assist devices.
心脏移植(HTx)是难治性终末期心力衰竭的一种治疗选择。移植前需要入住重症监护病房(ICU)的严重疾病可能是移植后生存率降低的一个风险因素,但在最近的研究中,这种关联出人意料地不一致。为了阐明入住ICU作为心脏移植结果风险因素的重要性,我们旨在确定患者年龄是否是入住ICU可预测HTx后生存率的一个因素。
从器官共享联合网络(UNOS)登记处获取了2006年至2015年期间进行的首次孤立性HTx的去识别数据。定义了九个年龄组。主要结局是移植后1年死亡率。Cox比例风险回归估计了每个年龄组中与移植前入住ICU相关的未调整和调整后的风险比(HR)。
分析纳入了19508例患者(9%在1年内死亡)。在整个队列中,移植前入住ICU与1年死亡率风险增加相关(HR = 1.3;95%置信区间(CI):1.2 - 1.4;P < 0.001);但进一步的单因素分析显示,婴儿入住ICU与1年死亡率风险增加更大相关(HR = 2.2;95% CI:1.5 - 3.2;P < 0.001)。然而,调整分析发现,40至49岁成年人的1年死亡率风险在统计学上最高(HR = 1.5;95% CI:1.1 - 2.1;P = 0.011)。
我们的研究确定了入住ICU与HTx后生存率之间的关联存在年龄差异,这种关联在接受HTx的40至49岁成年人中最为强烈。先前表明婴儿生存率降低的数据可能与体外膜肺氧合作为机械心脏辅助而非心室辅助装置的使用增加有关。